132 related articles for article (PubMed ID: 8830927)
1. Haemostatic factors and atherogenesis.
Smith EB
Atherosclerosis; 1996 Aug; 124(2):137-43. PubMed ID: 8830927
[TBL] [Abstract][Full Text] [Related]
2. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
Cantero M; Rojas H; Anglés-Cano E; Marchi R
BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
[TBL] [Abstract][Full Text] [Related]
3. Clot lysis mediated by cultured human microvascular endothelial cells.
Speiser W; Anders E; Binder BR; Müller-Berghaus G
Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
[TBL] [Abstract][Full Text] [Related]
4. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
5. [From fibrinogen to fibrin and its dissolution].
Juhan-Vague I; Hans M
Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
[TBL] [Abstract][Full Text] [Related]
6. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
7. Lipoproteins and the haemostatic system in atherothrombotic disorders.
Miller GJ
Baillieres Clin Haematol; 1994 Sep; 7(3):713-32. PubMed ID: 7841607
[TBL] [Abstract][Full Text] [Related]
8. Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury.
More RS; Underwood MJ; Brack MJ; de Bono DP; Gershlick AH
Cardiovasc Res; 1995 Jan; 29(1):22-6. PubMed ID: 7895234
[TBL] [Abstract][Full Text] [Related]
9. The plasminogen activator system and cancer.
McMahon B; Kwaan HC
Pathophysiol Haemost Thromb; 2008; 36(3-4):184-94. PubMed ID: 19176991
[TBL] [Abstract][Full Text] [Related]
10. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
Ishida T; Tanaka K
Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
[TBL] [Abstract][Full Text] [Related]
11. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Kostka B; Para J; Sikora J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
[TBL] [Abstract][Full Text] [Related]
12. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
Naito M; Stirk CM; Smith EB; Thompson WD
Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
[TBL] [Abstract][Full Text] [Related]
14. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
15. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
16. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
17. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
18. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
19. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
20. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
